Evidence map›Paper›PMID 25722794›Full record

ArticleOxidative medicine and cellular longevity2015

A novel antioxidant multitarget iron chelator M30 protects hepatocytes against ethanol-induced injury.

Jia Xiao, Yi Lv, Bin Lin, George L Tipoe, Moussa B H Youdim, Feiyue Xing, Yingxia Liu

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Iron Homeostasis and Liver Diseases.Journal of cellular and molecular medicine · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Liver Iron Loading in Alcohol-Associated Liver Disease.The American journal of pathology · 2023
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Jia XiaoNational Key Disciplines for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China ; Department of Immunobiology, Institute of Tissue Transplantation and Immunology, Jinan University, Guangzhou 510632, China ; Department of Anatomy, The University of Hong Kong, Pokfulam, Hong Kong.ORCID 0000-0001-5604-2494
Yi LvDepartment of Immunobiology, Institute of Tissue Transplantation and Immunology, Jinan University, Guangzhou 510632, China.
Bin LinDepartment of Anatomy, The University of Hong Kong, Pokfulam, Hong Kong.
George L TipoeDepartment of Anatomy, The University of Hong Kong, Pokfulam, Hong Kong.
Moussa B H YoudimEve Topf Centers of Excellence, Technion, Rappaport Family Faculty of Medicine and Department of Pharmacology, 31096 Haifa, Israel.
Feiyue XingDepartment of Immunobiology, Institute of Tissue Transplantation and Immunology, Jinan University, Guangzhou 510632, China.
Yingxia LiuNational Key Disciplines for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.
Jinan University · CNUniversity of Hong Kong · HKRappaport Family Institute for Research in the Medical Sciences · ILShenzhen Third People’s Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The multitarget iron chelator, M30, is a novel antioxidant and protective agent against oxidative stress in a spectrum of diseases. However, there is no report regarding its role in liver diseases. Since oxidative stress is one of the major pathological events during the progression of alcoholic liver diseases, the protective effects and mechanisms of M30 on ethanol-induced hepatocyte injury were investigated in this study. Rat hepatocyte line BRL-3A was pretreated with M30 prior to ethanol treatment. Cell death, apoptosis, oxidative stress, and inflammation were examined. Specific antagonists and agonists were applied to determine the involvements of hypoxia inducible factor-1 alpha (HIF-1α) and its upstream adenylate cyclase (AC)/cyclic AMP (cAMP)/protein kinase A (PKA)/HIF-1α/NOD-like receptor 3 (NLRP3) inflammasome pathway. We found that M30 significantly attenuated ethanol-induced cellular death, apoptosis, production of reactive oxygen species (ROS), and secretion of inflammatory cytokines and inhibited activation of the AC/cAMP/PKA/HIF-1α/NLRP3 inflammasome pathway. Inhibition and activation of the AC/cAMP/PKA/HIF-1α pathway mimicked and abolished the effects of M30, respectively. In conclusion, inhibition of the AC/cAMP/PKA/HIF-1α/NLRP3 inflammasome pathway by M30 partially contributes to its attenuation of hepatocyte injury caused by ethanol exposure.

Indexed as

Adenylyl CyclasesAnimalsAntioxidantsApoptosisCarrier ProteinsCell LineChelating AgentsCyclic AMPCyclic AMP-Dependent Protein KinasesEthanolHepatocytesHydroxyquinolinesHypoxia-Inducible Factor 1, alpha SubunitNLR Family, Pyrin Domain-Containing 3 ProteinOxidative StressRats5-(N-methyl-N-propargylaminomethyl)-8-hydroxyquinolineAdenylyl CyclasesAntioxidantsCarrier ProteinsChelating AgentsCyclic AMPCyclic AMP-Dependent Protein KinasesEthanolHydroxyquinolinesHypoxia-Inducible Factor 1, alpha SubunitNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratReactive Oxygen SpeciesReceptors, Cytoplasmic and Nuclear

Identifiers

PMID25722794
PMCPMC4334871
OpenAlexW1972897636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.